Physician profile
Jaime E Brown Price
NPI 1235368796
$1,302.43
in general payments reported to CMS, 2019-2025
23 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $52.94 · 2021: $24.74 · 2022: $218 · 2023: $219 · 2024: $336 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $226.57 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $147.61 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Daiichi Sankyo INC. | $124.93 | 2019-2025 | Injectafer |
| Exeltis, USA INC. | $120.88 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $114.76 | 2023-2024 | Veozah, Cresemba |
| Pfizer INC. | $91.53 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.46 | 2019-2024 | |
| Therapeuticsmd, INC. | $79.28 | 2019-2022 | |
| Medtronic, INC. | $49.73 | 2023 | Ligasure |
| Sumitomo Pharma America, INC. | $38.08 | 2024-2025 | Myfembree, Gemtesa |
| Novo Nordisk INC | $24.79 | 2019 | |
| Hologic Sales and Service, LLC | $21.79 | 2019 | |
| Sage Therapeutics, LLC | $20.47 | 2024 | |
| Mylan Pharmaceuticals INC. | $19.15 | 2022 | |
| Exact Sciences Corporation | $19.12 | 2025 | Cologuard Collection Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $18.59 | 2024 | |
| Ferring Pharmaceuticals INC. | $16.91 | 2019 | |
| Merck Sharp & Dohme LLC | $13.44 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.42 | 2019 | |
| Scynexis, INC. | $12.70 | 2022 | |
| Novum Pharma, LLC | $12.63 | 2019 | |
| Avion Pharmaceuticals | $12.47 | 2020 | |
| Coopersurgical, INC. | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Brown Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.